Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. It blocks viral entry into host cells while preserving normal immunologic function. The Company is also investigating an intramuscular method of administration of Trogarzo. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy.

TSX:TH - Post by User

Theratechnologies Inc

Bullboard Posts

Post by love_minus_zeroon Mar 18, 2010 10:10am

337 Views

Post# 16897593

Buying...

Buying opportunity.
RBC Buy TH with $6.50 target
Philippa (ex RBC) Sell TH with a $6.00 target
Is it just me or is it kinda hard to get to the $6 target after selling the shares at $5
At the same time Bloom and Burton (where Philippa works) recommend buying bio stocks that have lots of cash and partnership(s).
They are saying Buy out of one side of their mouth and Sell from the other side.
Go figure.
lmz

Bullboard Posts

Level up your trading with BMO InvestorLine’s enhanced features